Empowering Cancer Immunotherapy with Artificial Intelligence

Innovative software solutions to guide the discovery of neoantigen-based personalized immunotherapies and biomarkers.

Artificial Intelligence
Artificial Intelligence
Proprietary machine learning algorithms and data to predict antigen presentation and immunogenicity
Applied to the selection of patient specific targets in immuno-oncology clinical trials
Personalized<br/>Cancer Medicine
Cancer Medicine
Truly personalized and novel cancer immunotherapies to empower your neoantigen clinical trial success
Please enable your browser to accept cookies and refresh this page to enjoy the best experience from this website and to dismiss this message.
In order to provide you with the best online experience this website uses cookies. By using our website, you agree to our use of cookies.OK